United States · FDA National Drug Code directory
Awiqli
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0169-3105_8b15c5f6-3d6e-4e07-8118-7672c063baaa
- Product NDC
- 0169-3105
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Insulin icodec-abae
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260803
- Source listing expiry
- 20271231
Source-listed ingredients
- INSULIN ICODEC — 700 U/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (0169-3105-11) / 1.5 mL in 1 SYRINGE (0169-3105-01) · 0169-3105-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →